Search for Clinical Trial Results

Acromegaly - 141 Studies Found
Status | Study |
Recruiting |
Study Name: Lanreotide Levels in Acromegaly Condition: Acromegaly Date: 2009-06-09 Interventions: Other: Blood draw A blood draw will occur to take 10cc of blood to measure lanreotide levels. |
Recruiting |
Study Name: Treatment Patterns and Treatment Outcomes for Acromegaly Condition: Acromegaly Date: 2017-01-30 |
Not yet recruiting |
Study Name: The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research Condition: Acromegaly Date: 2017-05-06 Interventions:
|
Completed |
Study Name: Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study Condition: Acromegaly Date: 2008-05-27 |
Approved for marketing |
Study Name: An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly Condition: Acromegaly Date: 2013-11-20 Interventions: Drug: Pasireotide long acting release formulation Pasireotide LAR will be administered intramuscularly ( |
Recruiting |
Study Name: A Prospective Study of Outcome After Therapy for Acromegaly Condition: Acromegaly Date: 2012-08-08 Interventions:
|
Completed |
Study Name: Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR Condition: Acromegaly Date: 2005-09-13 Interventions: Drug: Lanreotide (Autogel formulation) |
Completed |
Study Name: Surgical Versus Medical Treatment of Acromegaly Condition: Acromegaly Date: 2009-10-21 |
Completed |
Study Name: Clomiphene Citrate for Treatment of Acromegaly Condition: Acromegaly Date: 2014-10-20 Interventions: Drug: Clomiphene Citrate Clomiphene citrate, 50 mg, orally for three months |
Completed |
Study Name: Treatment of Acromegaly With Somatostatin Analogs: GH vs. IGF-I as Primary Biochemical Target Condition: Acromegaly Date: 2012-06-04 Interventions: Drug: Sandostatin® LAR Intramuscular injections, dosage based on either GH or IGF-I levels. |